1
David P Kanios, Rod Hartwig, Juan A Mantelle, David W Houze: Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems. Noven Pharmaceuticals, Foley & Lardner, April 22, 2014: US08703175 (6 worldwide citation)

A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or rel ...


2
David Kanios, Rod Hartwig: Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems. Noven Pharmaceuticals, Foley & Lardner, January 1, 2013: US08343538 (5 worldwide citation)

A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is ...


3
Rod Hartwig, David Houze: Transdermal delivery of ketoprofen polar derivatives. Noven Pharmaceuticals, Foley & Lardner, August 2, 2011: US07989496 (5 worldwide citation)

A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen.


4
David Kanios, Rod Hartwig: Compositions and methods for delivering active agents in transdermal drug delivery systems. Noven Pharmaceuticals, Foley & Lardner, October 21, 2014: US08865207 (4 worldwide citation)

A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is ...


5
Rod Hartwig, David Kanios: Inhibiting crystallization of steroidal hormones in transdermal delivery systems. Noven Pharmaceuticals, Foley & Lardner, November 19, 2013: US08586080 (3 worldwide citation)

Compositions and methods for the continuous and controlled transdermal delivery of an active agent from a pharmaceutically acceptable carrier composition comprising a polyoxazoline polymer, wherein the active drug incorporated in the carrier composition of the transdermal system remains substantiall ...


6
David P Kanios, Rod Hartwig, Juan A Mantelle, David W Houze: Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems. Noven Pharmaceuticals, Foley And Lardner, August 4, 2005: US20050169977-A1

A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or rel ...


7
David Kanios, Rod Hartwig: Compositions and methods for delivering estradiol in transdermal drug delivery systems. Noven Pharmaceuticals, Dickstein Shapiro Morin & Oshinsky, April 13, 2006: US20060078601-A1

A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is ...


8
Rod HARTWIG, David HOUZE: Transdermal delivery of ketoprofen polar derivatives. Noven Pharmaceuticals, Foley And Lardner, March 5, 2009: US20090062394-A1

A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen.


9
David P Kanios, Rod Hartwig, Juan A Mantelle, David W Houze: Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems. Noven Pharmaceuticals, Foley And Lardner, December 9, 2010: US20100310610-A1

A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or rel ...


10
Rod Hartwig, David Houze: Transdermal delivery of ketoprofen polar derivates. Noven Pharmaceuticals, October 27, 2011: US20110263705-A1

A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen.